Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: Effect of hyperinsulinemia and lovastatin treatment

Pharmacology, Toxicology and Pharmaceutical Science

• Mevinolin 100%
• Hyperinsulinemia 100%
• Maturity Onset Diabetes of the Young 100%
• 1 Alkyl 2 Acetylglycerophosphocholine Esterase 100%
• Thrombocyte Activating Factor 62%
• Glucose 62%
• Insulin 62%
• Metabolic Syndrome X 25%
• Diabetic Obesity 25%
• Insulin Resistance 25%
• Scanning Electron Microscopy 12%
• Oxidoreductase 12%
• Acetic Acid Derivative 12%
• Low Density Lipoprotein Cholesterol 12%
• Diabetes Mellitus 12%
• Hyperglycemia 12%
• Hypercholesterolemia 12%
• Dyslipidemia 12%
• Fibrinogen 12%
• Phosphorylcholine 12%
• Hypercoagulability 12%
• Cardiovascular Disease 12%
• Hypertension 12%
• HMG-CoA 12%
• Hypocholesterolemic Agent 12%
• 1 O Alkylglycero 3 Phosphorylcholine 12%

Neuroscience

• Insulin 100%
• Lovastatin 100%
• Diabetes Mellitus 100%
• Blood Plasma 100%
• Hyperinsulinemia 100%
• 1 Alkyl 2 Acetylglycerophosphocholine Esterase 100%
• Platelet-Activating Factor 29%
• Glucose 23%
• Hypertension 5%
• Fibrinogen 5%
• Cholesterol 5%
• Hyperglycemia 5%
• Phosphorylcholine 5%
• Scanning Electron Microscopy 5%
• Cardiovascular System 5%
• Body Mass Index 5%
• Glucose Transport 5%
• Low Density Lipoprotein Cholesterol 5%
• Metabolic Pathway 5%
• B Cell 5%
• Dyslipidemia 5%
• Risk Factor 5%
• 1 O Alkylglycero 3 Phosphorylcholine 5%
• 3 Hydroxy 3 Methylglutaryl Coenzyme A 5%